サイクリン依存性キナーゼ6
関連文献

“Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence”. Nature 377 (6547 Suppl):  3–174. (Sep 1995). PMID 7566098. http://www.columbia.edu/itc/biology/pollack/w4065/client_edit/readings/nature377_3.pdf.
“Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase”. The Journal of Biological Chemistry 270 (31):  18195–7. (Aug 1995). doi:10.1074/jbc.270.31.18195. PMID 7629134.
“Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes”. Journal of Immunology 154 (12):  6275–84. (Jun 1995). PMID 7759865.
“Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer”. Cancer Research 55 (6):  1199–205. (Mar 1995). PMID 7882308.
“Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function”. Genes & Development 8 (24):  2939–52. (Dec 1994). doi:10.1101/gad.8.24.2939. PMID 8001816.
“Identification of G1 kinase activity for cdk6, a novel cyclin D partner”. Molecular and Cellular Biology 14 (3):  2077–86. (Mar 1994). doi:10.1128/MCB.14.3.2077. PMC 358568. PMID 8114739. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC358568/.
“Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A”. Current Biology 6 (1):  84–91. (Jan 1996). doi:10.1016/S0960-9822(02)00425-6. PMID 8805225.
“Normalization and subtraction: two approaches to facilitate gene discovery”. Genome Research 6 (9):  791–806. (Sep 1996). doi:10.1101/gr.6.9.791. PMID 8889548.
“Interaction between Cdc37 and Cdk4 in human cells”. Oncogene 14 (16):  1999–2004. (Apr 1997). doi:10.1038/sj.onc.1201036. PMID 9150368.
“Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation”. Journal of Immunology 158 (11):  5146–54. (Jun 1997). PMID 9164930.
“Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb”. Proceedings of the National Academy of Sciences of the United States of America 94 (20):  10699–704. (Sep 1997). doi:10.1073/pnas.94.20.10699. PMC 23451. PMID 9380698. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23451/.
“Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule”. Oncogene 16 (5):  587–96. (Feb 1998). doi:10.1038/sj.onc.1201580. PMID 9482104.
“Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes”. Carcinogenesis 19 (6):  1093–102. (Jun 1998). doi:10.1093/carcin/19.6.1093. PMID 9667749.
“Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a”. Nature 395 (6699):  237–43. (Sep 1998). doi:10.1038/26155. PMID 9751050.
“Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d”. Nature 395 (6699):  244–50. (Sep 1998). doi:10.1038/26164. PMID 9751051.
“Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6”. Proceedings of the National Academy of Sciences of the United States of America 96 (11):  6193–8. (May 1999). doi:10.1073/pnas.96.11.6193. PMC 26858. PMID 10339564. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC26858/.
“Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors”. Journal of the National Cancer Institute 91 (18):  1569–74. (Sep 1999). doi:10.1093/jnci/91.18.1569. PMID 10491434.
“Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1”. Cell 98 (6):  859–69. (Sep 1999). doi:10.1016/S0092-8674(00)81519-6. PMID 10499802.
“cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain”. The Journal of Biological Chemistry 274 (42):  29960–7. (Oct 1999). doi:10.1074/jbc.274.42.29960. PMID 10514479.